Skip to content

Combined effect of acupuncture and acupressure on lowering blood pressure: a pilot study

Combined effect of acupuncture and acupressure on lowering blood pressure: a pilot study - Acupuncture and acupressure for lowering blood pressure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041502
Enrollment
20
Registered
2020-09-01
Start date
2020-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension/High-normal blood pressure

Interventions

Acupuncture treatment (1 session/week, total 4 sessions) Acupressure (everyday at participant&#39
s home, total 28 sessions)

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Those who are able to join in the first and last examination. 2 Those with systolic blood pressure (SBP) 130 mmHg or diastolic blood pressure (DBP) 85 mmHg. 3 Those who joined in the explanation session and gave written informed consent.

Exclusion criteria

Exclusion criteria: 1 Those who have hypertension (SBP 140/ DBP 90) and who does not have the permission of doctor. 2 Those with secondary hypertension (diabetes mellitus, chronic kidney disease, endocrine disease etc). 3 Those with stage 2 hypertension (SBP 180 mmHg/DBP 110 mmHg). 4 Those with history of stroke or Myocardial infarction. 5 Pregnant women during this study period. 6 Those with metal allergies. 7 Those who are judged by the principal investigator to be unsuitable as a research subject.

Design outcomes

Primary

MeasureTime frame
Systolic and diastolic pressure Home blood pressure (morning/evening, 3 days)

Countries

Japan

Contacts

Public ContactKiyohide Tomooka

Juntendo University Department of Public Health, Faculty of Medicine

k-tomoka@juntendo.ac.jp03-5802-1049

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026